Literature DB >> 18830666

Factors affecting axillary lymph node retrieval and assessment in breast cancer patients.

T Cil1, J Hauspy, H Kahn, S Gardner, W Melnick, C Flynn, C M B Holloway.   

Abstract

BACKGROUND: Breast cancer is the most common female cancer in North America. Axillary lymph node dissection (ALND) is important for staging, prognosis, and adjuvant treatment decisions. The purpose of this study was to identify factors that affect the number of lymph nodes (LN) retrieved in ALND for breast cancer.
METHODS: All patients who underwent ALND for breast cancer at Sunnybrook Health Sciences Centre and Women's College Hospital between July 1999 and June 2006 were included. The number of LN retrieved was identified from pathology reports. Univariate and multivariate analysis was undertaken to identify variables influencing this outcome.
RESULTS: 1084 patients were identified with a mean number of LN of 14.5. In multivariate analyses, significant covariates included sentinel LN biopsy (P = 0.011), degree of extranodal extension (P = 0.005), tumor grade (P = 0.058), and age (P = 0.043). Thirteen percent of the variation in LN yield was accounted for by institutional, provider, patient, and tumor related factors, leaving 87% attributable to inherent biological or other differences between patients.
CONCLUSION: The yield of ALND may be influenced by multiple factors, often not related to the surgery. In settings where >10 LNs are routinely retrieved at ALND, biological variation between patients should be recognized as major a contributor to the LN yield. Adjuvant treatment decisions based on this outcome should take this into consideration.

Entities:  

Mesh:

Year:  2008        PMID: 18830666     DOI: 10.1245/s10434-008-9938-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  5 in total

1.  Outcomes of "one-day" vs "two-day" injection protocols using Tc-99m tilmanocept for sentinel lymph node biopsy in breast cancer.

Authors:  Jonathan T Unkart; James Proudfoot; Anne M Wallace
Journal:  Breast J       Date:  2018-03-02       Impact factor: 2.431

2.  Lymph node ratio may be supplementary to TNM nodal classification in node-positive breast carcinoma based on the results of 2,151 patients.

Authors:  Nüvit Duraker; Bakir Bati; Zeynep Civelek Çaynak; Davut Demir
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

3.  Prognostic Significance of the Number of Removed and Metastatic Lymph Nodes and Lymph Node Ratio in Breast Carcinoma Patients with 1-3 Axillary Lymph Node(s) Metastasis.

Authors:  Nüvit Duraker; Bakır Batı; Davut Demir; Zeynep Civelek Caynak
Journal:  ISRN Oncol       Date:  2011-10-12

4.  The prognostic value of lymph node cross-sectional cancer area in node-positive breast cancer: a comparison with N stage and lymph node ratio.

Authors:  Yanxia Li; Earle Holmes; Karan Shah; Kevin Albuquerque; Anna Szpaderska; Cağatay Erşahin
Journal:  Patholog Res Int       Date:  2012-10-04

5.  Clinical significance of extranodal extension in sentinel lymph node positive breast cancer.

Authors:  Xia Yang; XiaoXi Ma; Wentao Yang; Ruohong Shui
Journal:  Sci Rep       Date:  2020-09-07       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.